NCT05165446View on ClinicalTrials.gov

Novel MRE Technique to Assess a Risk Factor for Liver Cancer

Active, not recruitingOBSERVATIONAL

Enrollment

35

Participants

Timeline

Start Date

January 27, 2022

Primary Completion Date

January 1, 2024

Study Completion Date

September 30, 2025

Conditions

NASH - Nonalcoholic Steatohepatitis

Trial Locations (1)

94305

Stanford Hospital, Stanford

All Listed Sponsors

lead

Natalie Torok

OTHER